These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 31311662)
1. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation. Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662 [TBL] [Abstract][Full Text] [Related]
2. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of anticoagulant monotherapy in atrial fibrillation and stable coronary artery disease: A systematic review and meta-analysis. Ullah W; Sattar Y; Shaukat M; Fischman DL Eur J Intern Med; 2020 Nov; 81():54-59. PubMed ID: 32709546 [TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease. Ahmed M; Ahsan A; Shafiq A; Ahmed R; Alam M; Sabouret P; Rana JS; Fonarow GC Clin Cardiol; 2024 Oct; 47(10):e70026. PubMed ID: 39373259 [TBL] [Abstract][Full Text] [Related]
5. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events. Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG; Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742 [TBL] [Abstract][Full Text] [Related]
6. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T; Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700 [TBL] [Abstract][Full Text] [Related]
7. Short-term antiplatelet versus anticoagulant therapy after left atrial appendage closure: a systematic review and meta-analysis. Zhou Q; Liu X; Gu ZC; Yang X; Huang XH; Wu YZ; Tao YY; Wei M J Thromb Thrombolysis; 2024 Feb; 57(2):194-203. PubMed ID: 38180590 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation. Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244 [TBL] [Abstract][Full Text] [Related]
9. Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease. Lee SR; Jung JH; Choi EK; Lee SW; Kwon S; Park JS; Kang J; Han KD; Park KW; Oh S; Lip GYH Front Cardiovasc Med; 2022; 9():991293. PubMed ID: 36072876 [TBL] [Abstract][Full Text] [Related]
10. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry". Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575 [TBL] [Abstract][Full Text] [Related]
11. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
12. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries. Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Efficacy and Safety of Anticoagulant Monotherapy and Combined Therapy of Anticoagulant and Antiplatelets in Patients With Stable Coronary Artery Disease and Atrial Fibrillation: A Meta-Analysis. Tentu N; Ijaz A; Batool S; Khan RS; Mohammed F; Khan MH; Sandhu QI; Ali N Cureus; 2022 Sep; 14(9):e29772. PubMed ID: 36324348 [TBL] [Abstract][Full Text] [Related]
15. Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention. Park J; Choi EK; Han KD; Kim B; Choi YJ; Lee SR; Kang J; Cha MJ; Park KW; Oh S; Lip GYH PLoS One; 2020; 15(10):e0240161. PubMed ID: 33057407 [TBL] [Abstract][Full Text] [Related]
16. Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention. Khan SU; Khan MU; Ghani AR; Lone AN; Arshad A; Kaluski E Am J Cardiol; 2018 May; 121(10):1200-1206. PubMed ID: 29548674 [TBL] [Abstract][Full Text] [Related]
17. Association between antithrombotic therapy after stroke in patients with atrial fibrillation and the risk of net clinical outcome: an observational cohort study. Ahn HJ; Lee SR; Choi J; Lee KY; Kwon S; Choi EK; Oh S; Lip GYH Europace; 2024 Feb; 26(2):. PubMed ID: 38290433 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482 [TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial. Naito R; Miyauchi K; Yasuda S; Kaikita K; Akao M; Ako J; Matoba T; Nakamura M; Hagiwara N; Kimura K; Hirayama A; Matsui K; Ogawa H; JAMA Cardiol; 2022 Aug; 7(8):787-794. PubMed ID: 35704345 [TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. van Walraven C; Hart RG; Singer DE; Laupacis A; Connolly S; Petersen P; Koudstaal PJ; Chang Y; Hellemons B JAMA; 2002 Nov; 288(19):2441-8. PubMed ID: 12435257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]